Submit Deal

Announced

1 Jan 2023

Completed

1 Jan 2023

Novo and Bioqube Ventures led an €11m investment in Commit Biologics.

Synopsis

Novo, a life science investor, and Bioqube Ventures, a specialist life sciences investment firm, led an €11m investment in Commit Biologics, a biotech spin-out from Aarhus University.

Principals

target

Commit Biologics

bidder

Novo Holdings

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (3)

niels bang

Partner at Gorrissen Federspiel

Lawyer

target

Deals

£ 10.84 B

Total Value

nick stub laursen

CSO and Co-founder at COMMIT BIOLOGICS

Manager

target

Deal

£ 9 M

Total Value

caroline boysen

Associate at Gorrissen Federspiel

Lawyer

target

Deals

£ 8.12 B

Total Value

Bidder Team (2)

kasim kutay

CEO at NOVO HOLDINGS A/S

Investor

bidder

Deals

£ 26.73 B

Total Value

nico vandervelpen

Co-Founder and Managing Partner at BIOQUBE VENTURES

Manager

bidder

Deals

£ 99 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy